exëvo is a unique global supplier of innovative data management and analytics solutions
to the client is an integral part of the strategy to address integration and analysis
of complex research data. ...
exëvo supports Healthcare clients on all major industry issues. We offer broad consultancy and analytical services in key areas including market research, competitive intelligence, epidemiology studies, Key Opinion Leader management, and business development and licensing across all stages of the value chain.
Pharmaceutical and life sciences companies face an environment characterized by relentless challenge and change including many complex issues such as rising costs, greater market demand, and increasing numbers of patients. The industry remains under pressure from physicians, patients, payers, and regulators to deliver more effective treatments at lower cost. The current business model is based on development and marketing of blockbuster drugs, and is becoming more economically unsustainable and operationally unsuited to the rapid responsiveness to often complex issues demanded by stakeholders.
exëvo Healthcare provides global industry analysis, market research and forecasts, and insights to help address current trends and challenges, identify new technologies and take
advantage of opportunities to drive corporate growth.
exëvo offers a major advantage compared to regular healthcare research provided by our qualitative and quantitative marketing researchers - all insights and solutions offered by our industry and therapy area experts are supported by contemporary research. We offer genuine global coverage providing research and insights into North American, Latin American, European, Asian-Pacific, and Middle Eastern markets.
We help clients’ leverage their existing capabilities and maximize potential opportunities by providing comprehensive healthcare offerings intended to deliver valuable insights into their business at all lifecycle stages.
We help our clients to determine the optimal product concept, profile, targets, positioning, pricing and message; evaluate the optimal product portfolio, detail effectiveness and chances of market success; and track market performance.
The market landscape is constantly changing and information is expanding exponentially in a dynamic environment. Government regulations are escalating and managed care involvement is growing. At the same time, brand competition is increasing. We provide market intelligence services for business development strategies, identifying partners, prioritizing targets, evaluating opportunities, and negotiating deals. We help clients improve their decision-making capabilities in today's competitive environment.
We enable clients to maximize the commercial value of their development-stage and in-line products, and build or improve their marketing functions at the clinical phase, at launch, growth and development stages. We increase our clients' ability to evaluate the clinical, medical and commercial potential of compounds in early stage development either for further development or for licensing and partnering evaluation.
We mainly cover the following areas of market intelligence:
Traditionally, marketing of key healthcare products often involved dedicated concentration on sales and marketing activities. Today however, the market is moving towards adopting new sales models aimed at multi-channel stakeholder effectiveness.
Channel management of medical products is more challenging than ever and determining how best to structure the sales channels of the product is crucial. We can advise you on which channels of distribution will be most successful, conduct feasibility studies for direct sales operations and identify and assess potential distributors. We can also audit, manage and monitor your distributors to agreed performance and cost criteria. We communicate with key stakeholders, including payers, physicians, patients, pharmacists and other purchasers to address issues such as:
Increasingly, healthcare organizations face unprecedented challenges caused by changes in age and demographics, disease, advent of new technologies, increased government regulations and user requirements, and the rate of healthcare inflation. Moreover companies must adapt quickly and dramatically to operate effectively in the new industry environment.
We leverage an integrated approach to managing products and other related knowledge to enable our clients to improve the lives of others worldwide. Whether we join a project at any point from initial concept to end-of-life rationalization, we always provide comprehensive solutions while demonstrating our ability to operate either independently or as a fully integrated component of a client team.
We help maximizing the commercial performance of client products from initial launch through product maturity. Our analysts are experts in all aspects of healthcare marketing, including new product planning, commercial strategy development, brand planning, pharmaceutical product launches, and portfolio management solutions, as well as many other areas involved in maximizing the value of assets.
For in-market products, our research maximizes a brand’s commercial performance by focusing on positioning, differentiation and message recall, sales and marketing strategy insights, patient mapping, geographical factors, and therapy area portfolio management solutions.
Our research offerings include both industry and company analysis, product evaluation, valuations and business model analysis, commercial due diligence, benchmarking, and opportunity assessments.
We bring comprehensive experience covering all aspects of healthcare business while specializing in providing healthcare companies with specific market knowledge and recommendations necessary to ensure successful operational and strategic marketing decisions, and to optimize their competitive advantages.
© 2012 exëvo. All Rights Reserved
Scroll to top